Mirko Fillbrunn - Analysis Group , Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides Difficile Infection

Paul Feuerstadt,Jessica R. Allegretti,Erik R. Dubberke,Amy Guo,Adam Harvey,Min Yang,Viviana Garcia-Horton,Mirko Fillbrunn,Glenn Tillotson,Lindy L. Bancke,Kerry LaPlante,Kevin W. Garey,Sahil Khanna

Infectious Diseases and Therapyno. 1 (2024): 221-236

引用0浏览0WOS引用

MPN-539 Retrospective Real-World Analysis of Baseline Characteristics, Treatment Patterns, and Survival in Patients with Myelofibrosis and Anemia Receiving Ruxolitinib

Andrew T. Kuykendall,Mirko Fillbrunn,Tom Liu, Shiyuan Zhang,Adina Zhang,Ryan Simpson,Gautam Sajeev,James Signorovitch

Clinical Lymphoma Myeloma & Leukemia (2024): S206-S206

引用0浏览0引用

P-403 Indirect Comparison of Linvoseltamab Versus Selinexor Plus Dexamethasone for Penta-Exposed Relapsed/Refractory Multiple Myeloma (RRMM)

Jeffrey Zonder,Hans Lee,Joshua Richter,Naresh Bumma,Zheng-Yi Zhou,Viviana Garcia-Horton,Mirko Fillbrunn,Hongjue Wang, Matthew Mattera, Wenxin Ma,Qiufei Ma,Timothy Inocencio,Yingxin Xu, Evelien Bergrath,James Harnett,Tito Roccia,Glenn S. Kroog,Karen Rodriguez Lorenc,Yariv Houvras,Sundar Jagannath

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S267-S267

引用0浏览0引用

Lucia Masarova,Srdan Verstovsek,Tom Liu,Sumati Rao,Gautam Sajeev,Mirko Fillbrunn,Ryan Simpson, Weilong Li, Joseph Yang, Yvette Le Lorier,Boris Gorsh,James Signorovitch

FUTURE ONCOLOGYno. 30 (2024): 2259-2270

引用0浏览0WOS引用

Functional Trajectories Before and after Loss of Ambulation in Duchenne Muscular Dystrophy and Implications for Clinical Trials

Craig M. McDonald,James Signorovitch,Eugenio Mercuri,Erik H. Niks,Brenda Wong,Mirko Fillbrunn,Gautam Sajeev,Erica Yim,Ibrahima Dieye,Debra Miller,Susan J. Ward,Nathalie Goemans

PLOS ONEno. 6 (2024)

引用0浏览0WOS引用

MP71-11 REAL-WORLD TREATMENTS FOLLOWING BACILLUS CALMETTE-GUÉRIN INDUCTION IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: A CONTEMPORARY US CLAIMS ANALYSIS

Min Yang,Mirko Fillbrunn, Hesen Li,Adina Zhang, Ashton Moradi,Amy Guo,Ashish M. Kamat

JOURNAL OF UROLOGY（2024）

引用0浏览0引用

P-402 Indirect Comparison of Linvoseltamab Versus Teclistamab for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): an Updated Analysis Based on 14-Month Follow-Up Data

Hans Lee,Naresh Bumma,Joshua Richter,Jeffrey Zonder,James E. Hoffman,Zheng-Yi Zhou,Viviana Garcia-Horton,Mirko Fillbrunn,Hongjue Wang, Matthew Mattera, Wenxin Ma,Qiufei Ma,Timothy Inocencio,Yingxin Xu, Evelien Bergrath,James Harnett,Tito Roccia,Glenn S. Kroog,Karen Rodriguez Lorenc,Yariv Houvras

Clinical Lymphoma Myeloma and Leukemia (2024): S266-S267

引用0浏览0引用

Indirect Comparison of Linvoseltamab Versus Teclistamab for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): an Updated Analysis Based on 14-Month Follow-Up Data

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S266-S267

引用0浏览0引用

Indirect Comparison of Linvoseltamab Versus Teclistamab for Triple-Class Exposed (TCE) Relapsed/refractory Multiple Myeloma (RRMM)

Joshua Richter,Sundar Jagannath,Hans Lee,James E. Hoffman,Jeffrey Zonder,Zheng-Yi Zhou,Viviana Garcia-Horton,Mirko Fillbrunn,Hongjue Wang, Matthew Mattera, Wenxin Ma,Qiufei Ma,Timothy Inocencio,Yingxin Xu, Evelien Bergrath,James Harnett,Tito Roccia,Glenn S. Kroog,Karen Rodriguez Lorenc,Yariv Houvras,Naresh Bumma

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S274-S275

引用0浏览0引用

Retrospective Real-World Analysis of Baseline Characteristics and Posttreatment Hematologic Outcomes in Patients with Myelofibrosis Receiving Ruxolitinib

Andrew T. Kuykendall,Mirko Fillbrunn,Tom Liu,Adina Zhang,Ryan Simpson,Kelesitse Phiri,Gautam Sajeev,James Signorovitch

Bloodno. Supplement 1 (2023): 6399-6399

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn